Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 20, 2017
UPF1 Governs Synaptic Plasticity through Association with a STAU2 RNA Granule
Tyson E Graber, Erika Freemantle, Mina N Anadolu, et al.
Cancer Research
|
September 19, 2007
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
Xue Qing Lun, Hongyuan Zhou, Tommy Alain, et al.
Cancer Research
|
November 4, 2005
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas
Xueqing Lun, Wenqing Yang, Tommy Alain, et al.
Elife
|
April 6, 2017
La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs
Roni M Lahr, Bruno D Fonseca, Gabrielle E Ciotti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis
Armen Parsyan, David Shahbazian, Yvan Martineau, et al.
Science (New York, N.Y.)
|
May 29, 2010
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs
Ryan J O Dowling, Ivan Topisirovic, Tommy Alain, et al.
Oncotarget
|
September 9, 2017
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
Mamatha Bhat, Akiko Yanagiya, Tyson Graber, et al.
Oncogene
|
February 10, 2021
Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK
Xiao Xiang, Stéphanie Langlois, Marie-Eve St-Pierre, et al.
Cancer Research
|
October 27, 2012
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies
Tommy Alain, Masahiro Morita, Bruno D Fonseca, et al.
Journal of the National Cancer Institute
|
November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas
XueQing Lun, Donna L Senger, Tommy Alain, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
August 20, 2017
UPF1 Governs Synaptic Plasticity through Association with a STAU2 RNA Granule
Tyson E Graber, Erika Freemantle, Mina N Anadolu, et al.
Cancer Research
|
September 19, 2007
Targeting human medulloblastoma: oncolytic virotherapy with myxoma virus is enhanced by rapamycin
Xue Qing Lun, Hongyuan Zhou, Tommy Alain, et al.
Cancer Research
|
November 4, 2005
Myxoma virus is a novel oncolytic virus with significant antitumor activity against experimental human gliomas
Xueqing Lun, Wenqing Yang, Tommy Alain, et al.
Elife
|
April 6, 2017
La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs
Roni M Lahr, Bruno D Fonseca, Gabrielle E Ciotti, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2009
The helicase protein DHX29 promotes translation initiation, cell proliferation, and tumorigenesis
Armen Parsyan, David Shahbazian, Yvan Martineau, et al.
Science (New York, N.Y.)
|
May 29, 2010
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs
Ryan J O Dowling, Ivan Topisirovic, Tommy Alain, et al.
Oncotarget
|
September 9, 2017
Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cells
Mamatha Bhat, Akiko Yanagiya, Tyson Graber, et al.
Oncogene
|
February 10, 2021
Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAK
Xiao Xiang, Stéphanie Langlois, Marie-Eve St-Pierre, et al.
Cancer Research
|
October 27, 2012
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies
Tommy Alain, Masahiro Morita, Bruno D Fonseca, et al.
Journal of the National Cancer Institute
|
November 2, 2006
Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas
XueQing Lun, Donna L Senger, Tommy Alain, et al.
Page
of 11